Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17606) 17606
Newspaper Article (971) 971
Book Chapter (153) 153
Magazine Article (81) 81
Publication (37) 37
Conference Proceeding (30) 30
Dissertation (20) 20
Trade Publication Article (6) 6
Book / eBook (5) 5
Book Review (4) 4
Government Document (2) 2
Journal / eJournal (2) 2
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11605) 11605
science & technology (10197) 10197
life sciences & biomedicine (9530) 9530
molecular weight (7637) 7637
female (5132) 5132
heparin, low-molecular-weight - therapeutic use (5009) 5009
male (4656) 4656
biological and medical sciences (4426) 4426
animals (3698) 3698
anticoagulants - therapeutic use (3671) 3671
medical sciences (3361) 3361
heparin (2890) 2890
middle aged (2792) 2792
adult (2616) 2616
aged (2482) 2482
anticoagulants (2361) 2361
heparin, low-molecular-weight - administration & dosage (2308) 2308
cardiovascular system & cardiology (2263) 2263
hematology (2141) 2141
low molecular weight heparin (1927) 1927
risk factors (1884) 1884
pharmacology. drug treatments (1837) 1837
heparin, low-molecular-weight - adverse effects (1716) 1716
anticoagulants - administration & dosage (1708) 1708
peripheral vascular disease (1680) 1680
abridged index medicus (1587) 1587
thrombosis (1519) 1519
anticoagulants - adverse effects (1495) 1495
treatment outcome (1485) 1485
heparin - therapeutic use (1434) 1434
thromboembolism (1430) 1430
low-molecular-weight heparin (1418) 1418
pregnancy (1356) 1356
fundamental and applied biological sciences. psychology (1329) 1329
blood. blood coagulation. reticuloendothelial system (1323) 1323
general & internal medicine (1279) 1279
surgery (1185) 1185
heparin, low-molecular-weight - pharmacology (1171) 1171
heparin - pharmacology (1143) 1143
venous thromboembolism (1115) 1115
biochemistry & molecular biology (1090) 1090
fibrinolytic agents - therapeutic use (1074) 1074
proteins (1070) 1070
rats (1048) 1048
medicine, general & internal (1038) 1038
thromboembolism - prevention & control (1009) 1009
venous thrombosis - prevention & control (1003) 1003
pharmacology & pharmacy (947) 947
venous thrombosis - drug therapy (934) 934
aged, 80 and over (919) 919
postoperative complications - prevention & control (869) 869
time factors (860) 860
drug therapy (850) 850
analysis (828) 828
pulmonary embolism (819) 819
prospective studies (815) 815
research (805) 805
venous thromboembolism - prevention & control (787) 787
care and treatment (781) 781
cardiac & cardiovascular systems (774) 774
retrospective studies (766) 766
heparin - adverse effects (752) 752
cancer (751) 751
hemorrhage - chemically induced (745) 745
heparin - administration & dosage (745) 745
dose-response relationship, drug (739) 739
patients (739) 739
kinetics (726) 726
anticoagulants - pharmacology (721) 721
mice (721) 721
mortality (688) 688
chemistry (640) 640
health aspects (633) 633
electrophoresis, polyacrylamide gel (625) 625
cardiology. vascular system (617) 617
research article (606) 606
molecular sequence data (588) 588
pulmonary embolism - prevention & control (585) 585
randomized controlled trials as topic (584) 584
physical sciences (582) 582
thrombosis - prevention & control (580) 580
amino acid sequence (566) 566
blood coagulation - drug effects (561) 561
glycosaminoglycans (561) 561
venous thrombosis (561) 561
medicine (560) 560
adolescent (549) 549
medicine & public health (537) 537
anticoagulation (532) 532
cells, cultured (532) 532
oncology (532) 532
cattle (522) 522
warfarin - therapeutic use (522) 522
deep vein thrombosis (521) 521
venous thrombosis - etiology (521) 521
prevention (518) 518
molecular and cellular biology (508) 508
heparin - metabolism (507) 507
risk assessment (507) 507
warfarin (507) 507
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17284) 17284
German (598) 598
French (508) 508
Japanese (166) 166
Russian (156) 156
Spanish (145) 145
Chinese (131) 131
Polish (82) 82
Italian (60) 60
Czech (51) 51
Hungarian (34) 34
Portuguese (34) 34
Danish (29) 29
Dutch (26) 26
Swedish (22) 22
Norwegian (19) 19
Turkish (16) 16
Bulgarian (15) 15
Korean (14) 14
Finnish (11) 11
Slovak (8) 8
Croatian (7) 7
Hebrew (6) 6
Serbian (5) 5
Slovenian (5) 5
Ukrainian (4) 4
Lithuanian (3) 3
Romanian (2) 2
Bosnian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
by Hirsh, Jack and Warkentin, Theodore E and Shaughnessy, Stephen G and Anand, Sonia S and Halperin, Jonathan L and Raschke, Robert and Granger, Christopher and Ohman, E. Magnus and Dalen, James E
Chest, ISSN 0012-3692, 01/2001, Volume 119, Issue 1, pp. 64S - 94S
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Blood. Blood coagulation. Reticuloendothelial system | Pharmacology. Drug treatments | Heparin, Low-Molecular-Weight - pharmacology | Venous Thrombosis - drug therapy | Humans | Heparin, Low-Molecular-Weight - adverse effects | Anticoagulants - therapeutic use | Heparin - therapeutic use | Anticoagulants - adverse effects | Heparin - adverse effects | Heparin, Low-Molecular-Weight - therapeutic use | Heparin - pharmacokinetics | Heparin, Low-Molecular-Weight - pharmacokinetics | Myocardial Infarction - drug therapy | Angina, Unstable - drug therapy | Anticoagulants - pharmacology | Coronary Disease - drug therapy | Venous Thrombosis - prevention & control | Anticoagulants - pharmacokinetics | Heparin - pharmacology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Heparin and low-molecular-weight heparin: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
by Hirsh, Jack and Raschke, Robert
Chest, ISSN 0012-3692, 2004, Volume 126, Issue 3, pp. 188S - 203S
Pentasaccharide | Heparin | Low-molecular-weight heparin | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Pneumology | Drug Administration Schedule | Humans | Heparin, Low-Molecular-Weight - adverse effects | Biological Availability | Heparin - therapeutic use | Hemorrhage - blood | Evidence-Based Medicine | Heparin - adverse effects | Heparin, Low-Molecular-Weight - therapeutic use | Heparin - pharmacokinetics | Metabolic Clearance Rate - physiology | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Hemorrhage - drug therapy | Fibrinolytic Agents - pharmacokinetics | Kidney Failure, Chronic - blood | Partial Thromboplastin Time | Fibrinolytic Agents - therapeutic use | Antithrombin III - metabolism | Protamines - therapeutic use | Hemorrhage - chemically induced | Heparin Antagonists - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Unfractionated heparin versus low molecular weight heparins for avoiding heparin‐induced thrombocytopenia in postoperative patients
by Junqueira, Daniela R and Zorzela, Liliane M and Perini, Edson and Junqueira, Daniela R
Cochrane library, ISSN 1469-493X, 04/2017, Volume 2017, Issue 4, pp. CD007557 - CD007557
Thrombocytopenia | Anticoagulants | Heparin_induced thrombocytopenia (HIT) | Surgical Procedures, Operative | Medical prophylaxis | Medical treatment | Venous Thrombosis | Deep vein thrombosis | Heparin, Low‐Molecular‐Weight | Thrombosis | Randomized Controlled Trials as Topic | Pulmonary embolism | Prevention | Pulmonary Embolism (PE) | Blood disorders | Numbers Needed To Treat | Treatment | Deep vein thrombosis (DVT) related | Prevention: medical approaches | Heparin | Heart & circulation | Medicine General & Introductory Medical Sciences | Thromboembolism | Postoperative Complications | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anticoagulants - administration & dosage | Humans | Postoperative Complications - prevention & control | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Surgical Procedures, Operative - statistics & numerical data | Thrombocytopenia - chemically induced | Anticoagulants - adverse effects | Heparin - adverse effects | Thrombocytopenia - complications | Venous Thrombosis - etiology | Thrombosis - etiology | Thrombocytopenia - prevention & control | Venous Thrombosis - prevention & control | Heparin, Low-Molecular-Weight - administration & dosage | Thrombosis - prevention & control | Postoperative Complications - chemically induced | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials
by Gould, Michael K and Dembitzer, Anne D and Doyle, Ramona L and Hastie, Trevor J and Garber, Alan M
Annals of internal medicine, ISSN 0003-4819, 05/1999, Volume 130, Issue 10, pp. 800 - 809
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Blood. Blood coagulation. Reticuloendothelial system | Pharmacology. Drug treatments | Recurrence | Double-Blind Method | Venous Thrombosis - drug therapy | Humans | Venous Thrombosis - mortality | Heparin, Low-Molecular-Weight - adverse effects | Anticoagulants - therapeutic use | Heparin - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Heparin, Low-Molecular-Weight - therapeutic use | Randomized Controlled Trials as Topic | Analysis of Variance | Sensitivity and Specificity | Hemorrhage - chemically induced | Research Design | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights